Literature DB >> 22553926

Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.

Hanna B Kern1, Brian F Niemeyer, Janet K Parrish, Carol A Kerr, Nasser K Yaghi, Jason D Prescott, Arthur Gutierrez-Hartmann, Paul Jedlicka.   

Abstract

MicroRNAs (miRs) are important regulators of gene expression in normal physiology and disease, and are widely misexpressed in cancer. A number of studies have identified miR-21 as an important promoter of oncogenesis. However, as is true of most miRs, the mechanisms behind the aberrant expression of miR-21 in cancer are poorly understood. Herein, we examine the regulation of miR-21 expression in colorectal cancer (CRC) cells by the oncogenic epidermal growth factor (EGF)/Ras pathway and by Ets transcription factors, modulators of epithelial oncogenesis that are frequently misexpressed in CRC. We show that EGF/Ras efficiently induces the miR-21 primary transcript, but this does not rapidly and simply translate into higher mature miR-21 levels. Rather, induction of mature miR-21 by constitutive activation of this pathway is slow, is associated with only minimal activation of mitogen-activated protein kinase, and may involve stimulation of post-transcriptional processing by mechanisms other than Dicer stabilization. We further identify Ets transcription factors as modifiers of miR-21 expression in CRC. The effects of Ets factors on miR-21 expression are cell context-dependent, and appear to involve both direct and indirect mechanisms. The Ets factor Pea3 emerges from our studies as a consistent repressor of miR-21 transcription. Overall, our studies identify a complex relationship between oncogenic pathways and steady-state miR-21 levels in CRC, and highlight the need for greater understanding of the control of miR expression in cancer and other disease states.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553926      PMCID: PMC3405454          DOI: 10.1089/dna.2011.1469

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  36 in total

Review 1.  Biogenesis of small RNAs in animals.

Authors:  V Narry Kim; Jinju Han; Mikiko C Siomi
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02       Impact factor: 94.444

Review 2.  Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway.

Authors:  B Wasylyk; J Hagman; A Gutierrez-Hartmann
Journal:  Trends Biochem Sci       Date:  1998-06       Impact factor: 13.807

3.  A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs.

Authors:  E L McKinsey; J K Parrish; A E Irwin; B F Niemeyer; H B Kern; D K Birks; P Jedlicka
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

4.  miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism.

Authors:  Shuji Fujita; Taiji Ito; Taketoshi Mizutani; Shigeru Minoguchi; Nobutake Yamamichi; Kouhei Sakurai; Hideo Iba
Journal:  J Mol Biol       Date:  2008-03-15       Impact factor: 5.469

5.  Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

Authors:  Dennis Löffler; Katja Brocke-Heidrich; Gabriele Pfeifer; Claudia Stocsits; Jörg Hackermüller; Antje K Kretzschmar; Renate Burger; Martin Gramatzki; Conny Blumert; Kay Bauer; Helena Cvijic; A Kerstin Ullmann; Peter F Stadler; Friedemann Horn
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

6.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

Review 7.  MiRNAs and cancer.

Authors:  Rosa Visone; Carlo M Croce
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

8.  SMAD proteins control DROSHA-mediated microRNA maturation.

Authors:  Brandi N Davis; Aaron C Hilyard; Giorgio Lagna; Akiko Hata
Journal:  Nature       Date:  2008-06-11       Impact factor: 49.962

Review 9.  Small silencing RNAs: an expanding universe.

Authors:  Megha Ghildiyal; Phillip D Zamore
Journal:  Nat Rev Genet       Date:  2009-02       Impact factor: 53.242

10.  The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice.

Authors:  Paul Jedlicka; Xiaomei Sui; Arthur Gutierrez-Hartmann
Journal:  BMC Cancer       Date:  2009-06-22       Impact factor: 4.430

View more
  9 in total

1.  MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.

Authors:  Bo Gong; Wan-Wei Liu; Wen-Jing Nie; Dong-Feng Li; Zi-Jun Xie; Chao Liu; Yan-Hui Liu; Ping Mei; Zi-Jun Li
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner.

Authors:  Yuanyuan Mi; Lifeng Zhang; Chuanyu Sun; Yanyan Feng; Jian Sun; Jun Wang; Dongjie Yang; Xiaowei Qi; Hongyuan Wan; Guowei Xia; Sheng Wu; Lijie Zhu
Journal:  J Cell Commun Signal       Date:  2022-05-18       Impact factor: 5.782

Review 3.  MicroRNAs targeting EGFR signalling pathway in colorectal cancer.

Authors:  Jitka Mlcochova; Petra Faltejskova; Radim Nemecek; Marek Svoboda; Ondrej Slaby
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-02       Impact factor: 4.553

4.  Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues.

Authors:  Maurizio Callari; Matteo Dugo; Valeria Musella; Edoardo Marchesi; Giovanna Chiorino; Maurizia Mello Grand; Marco Alessandro Pierotti; Maria Grazia Daidone; Silvana Canevari; Loris De Cecco
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.

Authors:  Yingjie Yu; Pratima Nangia-Makker; Lulu Farhana; Sindhu G Rajendra; Edi Levi; Adhip P N Majumdar
Journal:  Mol Cancer       Date:  2015-05-01       Impact factor: 27.401

6.  Human mesenchymal stem cells suppress the stretch-induced inflammatory miR-155 and cytokines in bronchial epithelial cells.

Authors:  Yi-Chun Kuo; Yi-Shuan Julie Li; Jing Zhou; Yu-Ru Vernon Shih; Marina Miller; David Broide; Oscar Kuang-Sheng Lee; Shu Chien
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

7.  MicroRNA-766-3p-mediated downregulation of HNF4G inhibits proliferation in colorectal cancer cells through the PI3K/AKT pathway.

Authors:  Xin-Xin He; Shan-Shan Luo; Hai-Quan Qin; Xian-Wei Mo
Journal:  Cancer Gene Ther       Date:  2021-06-22       Impact factor: 5.854

8.  MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1.

Authors:  Xinxin He; Yangnian Wei; Yong Wang; Ling Liu; Wen Wang; Nianfeng Li
Journal:  Onco Targets Ther       Date:  2016-03-07       Impact factor: 4.147

9.  Pluronic-based micelle encapsulation potentiates myricetin-induced cytotoxicity in human glioblastoma cells.

Authors:  Xiang-Jun Tang; Kuan-Ming Huang; Hui Gui; Jun-Jie Wang; Jun-Ti Lu; Long-Jun Dai; Li Zhang; Gang Wang
Journal:  Int J Nanomedicine       Date:  2016-10-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.